These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Alternative Wnt-signaling axis leads to a break of oncogene-induced senescence. Kluge V; Kappelmann-Fenzl M; Fischer S; Zimmermann T; Pommer M; Kuphal S; Bosserhoff AK Cell Death Dis; 2024 Feb; 15(2):166. PubMed ID: 38388496 [TBL] [Abstract][Full Text] [Related]
4. Oncogene-Expressing Senescent Melanocytes Up-Regulate MHC Class II, a Candidate Melanoma Suppressor Function. van Tuyn J; Jaber-Hijazi F; MacKenzie D; Cole JJ; Mann E; Pawlikowski JS; Rai TS; Nelson DM; McBryan T; Ivanov A; Blyth K; Wu H; Milling S; Adams PD J Invest Dermatol; 2017 Oct; 137(10):2197-2207. PubMed ID: 28647344 [TBL] [Abstract][Full Text] [Related]
5. C-MYC overexpression is required for continuous suppression of oncogene-induced senescence in melanoma cells. Zhuang D; Mannava S; Grachtchouk V; Tang WH; Patil S; Wawrzyniak JA; Berman AE; Giordano TJ; Prochownik EV; Soengas MS; Nikiforov MA Oncogene; 2008 Nov; 27(52):6623-34. PubMed ID: 18679422 [TBL] [Abstract][Full Text] [Related]
6. Oncogene activation in melanocytes links reactive oxygen to multinucleated phenotype and senescence. Leikam C; Hufnagel A; Schartl M; Meierjohann S Oncogene; 2008 Nov; 27(56):7070-82. PubMed ID: 18806824 [TBL] [Abstract][Full Text] [Related]
7. Human chorionic gonadotropin-induced amphiregulin stimulates aromatase expression in human granulosa-lutein cells: a mechanism for estradiol production in the luteal phase. Fang L; Yu Y; Li Y; Wang S; Zhang R; Guo Y; Li Y; Yan Y; Sun YP Hum Reprod; 2019 Oct; 34(10):2018-2026. PubMed ID: 31553790 [TBL] [Abstract][Full Text] [Related]
8. A key role for mitochondrial gatekeeper pyruvate dehydrogenase in oncogene-induced senescence. Kaplon J; Zheng L; Meissl K; Chaneton B; Selivanov VA; Mackay G; van der Burg SH; Verdegaal EM; Cascante M; Shlomi T; Gottlieb E; Peeper DS Nature; 2013 Jun; 498(7452):109-12. PubMed ID: 23685455 [TBL] [Abstract][Full Text] [Related]
9. The role of BRAF mutation and p53 inactivation during transformation of a subpopulation of primary human melanocytes. Yu H; McDaid R; Lee J; Possik P; Li L; Kumar SM; Elder DE; Van Belle P; Gimotty P; Guerra M; Hammond R; Nathanson KL; Dalla Palma M; Herlyn M; Xu X Am J Pathol; 2009 Jun; 174(6):2367-77. PubMed ID: 19389934 [TBL] [Abstract][Full Text] [Related]
10. Amphiregulin mediates non-cell-autonomous effect of senescence on reprogramming. von Joest M; Chen C; Douché T; Chantrel J; Chiche A; Gianetto QG; Matondo M; Li H Cell Rep; 2022 Jul; 40(2):111074. PubMed ID: 35830812 [TBL] [Abstract][Full Text] [Related]
11. Amphiregulin promotes BAX inhibition and resistance to gefitinib in non-small-cell lung cancers. Busser B; Sancey L; Josserand V; Niang C; Favrot MC; Coll JL; Hurbin A Mol Ther; 2010 Mar; 18(3):528-35. PubMed ID: 19826406 [TBL] [Abstract][Full Text] [Related]
12. Cross-suppression of EGFR ligands amphiregulin and epiregulin and de-repression of FGFR3 signalling contribute to cetuximab resistance in wild-type KRAS tumour cells. Oliveras-Ferraros C; Cufí S; Queralt B; Vazquez-Martin A; Martin-Castillo B; de Llorens R; Bosch-Barrera J; Brunet J; Menendez JA Br J Cancer; 2012 Apr; 106(8):1406-14. PubMed ID: 22491422 [TBL] [Abstract][Full Text] [Related]
13. Targeting amphiregulin (AREG) derived from senescent stromal cells diminishes cancer resistance and averts programmed cell death 1 ligand (PD-L1)-mediated immunosuppression. Xu Q; Long Q; Zhu D; Fu D; Zhang B; Han L; Qian M; Guo J; Xu J; Cao L; Chin YE; Coppé JP; Lam EW; Campisi J; Sun Y Aging Cell; 2019 Dec; 18(6):e13027. PubMed ID: 31493351 [TBL] [Abstract][Full Text] [Related]
14. Multiple myeloma-derived exosomes are enriched of amphiregulin (AREG) and activate the epidermal growth factor pathway in the bone microenvironment leading to osteoclastogenesis. Raimondo S; Saieva L; Vicario E; Pucci M; Toscani D; Manno M; Raccosta S; Giuliani N; Alessandro R J Hematol Oncol; 2019 Jan; 12(1):2. PubMed ID: 30621731 [TBL] [Abstract][Full Text] [Related]
15. Amphiregulin potentiates airway inflammation and mucus hypersecretion induced by urban particulate matter via the EGFR-PI3Kα-AKT/ERK pathway. Wang J; Zhu M; Wang L; Chen C; Song Y Cell Signal; 2019 Jan; 53():122-131. PubMed ID: 30291869 [TBL] [Abstract][Full Text] [Related]
16. The Epidermal Growth Factor Receptor Ligand Amphiregulin Protects From Cholestatic Liver Injury and Regulates Bile Acids Synthesis. Santamaría E; Rodríguez-Ortigosa CM; Uriarte I; Latasa MU; Urtasun R; Alvarez-Sola G; Bárcena-Varela M; Colyn L; Arcelus S; Jiménez M; Deutschmann K; Peleteiro-Vigil A; Gómez-Cambronero J; Milkiewicz M; Milkiewicz P; Sangro B; Keitel V; Monte MJ; Marin JJG; Fernández-Barrena MG; Ávila MA; Berasain C Hepatology; 2019 Apr; 69(4):1632-1647. PubMed ID: 30411380 [TBL] [Abstract][Full Text] [Related]